D-0647-2017 Class III Terminated

Recalled by Fresenius Kabi USA, LLC — Lake Zurich, IL

FDA drug recall D-0647-2017 was initiated by Fresenius Kabi USA, LLC on Mar 16, 2017 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Aug 28, 2018). Affected quantity: 118,224 vials.

Recall details

Product Type
Drugs
Report Date
Apr 12, 2017
Initiation Date
Mar 16, 2017
Termination Date
Aug 28, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
118,224 vials

Product description

Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide within the US

Code information

Lot #: 6111141, Exp. 07/17; 6111222, Exp. 08/17; 6112346, Exp. 01/18; 6112725, Exp. 03/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0647-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0647-2017. Report a data issue: hello@regdatalab.com.